Steve Yoo

Steve Yoo

Senior Analyst, Public Equity

Steve joined Sofinnova as an Associate in 2017.  In 2019, he was promoted to Senior Analyst. He focuses on public investments in global therapeutics companies. He has more than a decade of sell-side and buy-side experience following therapeutics companies.

Before joining Sofinnova, Steve covered therapeutics companies at Surveyor Capital, a global multi-strategy hedge fund associated with Citadel LLC. Prior to this, he was a senior manager of finance at Amgen, a global biotech company where he conducted Aranesp sales forecasts. Additionally, he worked as a sell-side biotech analyst/associate at Leerink Partners, UBS and Sanford C. Bernstein.

Steve received his Masters of Business and Science from Keck Graduate Institute and his B.S. from MIT.